Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538756 · ClinicalTrials.gov registry record · NA
walk2Wellness: Long-term Effects of Walkasins® Wearable Sensory Prosthesis
A NA study, sponsored by RxFunction.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT03538756 is a NA study that has completed, run by RxFunction. The registered enrollment target is 69 participants.
The verdict
NCT03538756, a NA study, has completed, sponsored by RxFunction.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the long-term effects of Walkasins® use on clinical and subject-reported outcomes of balance and gait function, quality of life, physical activity/participation, pain, and medication use in persons with peripheral neuropathy who experience balance problems.
Interventions
- DEVICE Walkasins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03538756
The ClinicalTrials.gov registry entry for NCT03538756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RxFunction, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Walkasins is the first listed.
NCT03538756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03538756 about?
NCT03538756 is a clinical study titled "walk2Wellness: Long-term Effects of Walkasins® Wearable Sensory Prosthesis". The purpose of this study is to investigate the long-term effects of Walkasins® use on clinical and subject-reported outcomes of balance and gait function, quality of life, physical activity/participation, pain, and medication use in persons with peripheral neuropathy who experience balance problems...
What is the current status of trial NCT03538756?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2018-10-22. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03538756?
The interventions under investigation include: Walkasins (DEVICE).
Who is sponsoring clinical trial NCT03538756?
This trial is sponsored by RxFunction, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.